Condition
Rejection of Renal Transplant
Total Trials
4
Recruiting
0
Active
0
Completed
4
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
25%
1 of 4 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
2Total
P 2 (1)
P 3 (1)
Trial Status
Completed4
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT03206801Phase 2Completed
Urine CXCL10 Monitoring Trial in Kidney Transplant
NCT03289650Phase 3Completed
Extended Release Tacrolimus vs. Twice-Daily Tacrolimus
NCT03317925Completed
Renal Transplant Injury and the Renin-Angiotensin System in Kids (RETASK)
NCT01315067CompletedPrimary
Diagnosis of Acute Rejection in Renal Transplant Patients by Urine Mass Spectrometry
Showing all 4 trials